Cancer, Gastric Clinical Trial
Official title:
Gastric Cancer Risk Factors Associated With EU and CELAC Populations
The study uses a case-control design that examines the differences in types of exposures between cases defined with a pathological confirmation of GC diagnosis, and controls, defined as patients to whom a gastroscopy was indicated and confirmed absent of GC i
GC is associated to several known risk factors. Epidemiological and molecular features of GCs can vary widely. The reasons behind these differences are multiple and complex and may include genetic susceptibility, strains of the bacterium Helicobacter pylori (H. pylori), Epstein Barr virus infection, dietary factors and others. These factors can influence GC outcomes. There is little knowledge regarding how these risk factors are associated with GC in CELAC and EU populations. The primary objectives of this study are to: 1. Identify risk factors associated with GC in the CELAC and EU populations participating in this study including Argentina, Spain, Mexico, Netherlands, Chile, Portugal and Paraguay. 2. Identify clinical, demographic, and epidemiological differences among the populations participating in this study ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06391749 -
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
|
||
| Recruiting |
NCT05227261 -
Early Detection of Five Common Cancers Using the ctDNA Analysing Test
|